Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
For nearly a century, Cannabis has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in Cannabis due to the therapeutic potential of phytocannabinoids. With this emerging interest in Cannabis, concerns have arisen about the possible contaminat...
Main Authors: | Zackary Montoya, Matthieu Conroy, Brian D. Vanden Heuvel, Christopher S. Pauli, Sang-Hyuck Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.571832/full |
Similar Items
-
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
by: Christopher S. Pauli, et al.
Published: (2020-02-01) -
Research and Clinical Practice Involving the Use of <i>Cannabis</i> Products, with Emphasis on Cannabidiol: A Narrative Review
by: João Luís Q. Simei, et al.
Published: (2024-12-01) -
From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
by: Rafael M. Bitencourt, et al.
Published: (2021-02-01) -
Limited effect of environmental stress on cannabinoid profiles in high‐cannabidiol hemp (Cannabis sativa L.)
by: Jacob A. Toth, et al.
Published: (2021-10-01) -
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
by: Tommaso Cassano, et al.
Published: (2020-03-01)